Five things to know:
1. Samuel Hazen, who became CEO of HCA in January 2019, received a base salary of $1.48 million last year, compared to $1.34 million in 2020. Mr. Hazen and other top HCA executives took a 30 percent salary reduction from April 1, 2020, through June 30, 2020, in response to the COVID-19 pandemic.
2. After factoring in incentive compensation, stock awards and pension benefits, Mr. Hazen’s compensation totaled $20.64 million in 2021, compared to $30.4 million a year earlier, according to the proxy statement.
3. HCA Executive Vice President and CFO William Rutherford’s salary increased from $831,251 in 2020 to $916,743 in 2021. He ended last year with total compensation of $7.16 million, up from $6.13 million in 2020.
4. HCA American Group President Jon Foster and National Group President Charles Hall each received a salary of $899,113 in 2021, up from $815,264 in 2020. Mr. Foster’s compensation totaled $6.05 million last year, and Mr. Hall’s compensation totaled $5.63 million.
5. Michael Cuffe, MD, the president of the company’s physician services group, received a salary of $694,435 in 2021 and total compensation of $5.16 million. He stepped into the role Jan. 1. Dr. Cuffe, who joined HCA in 2011, previously served as president and CEO of physician services.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
